The Food and Drug Administration (FDA) has approved AKLIEF (trifarotene) Cream 0.005% for the topical treatment of acne.
Global pharmaceutical company Galderma’s liquid formulation of botulinum toxin type A has achieved positive results for the treatment of glabellar lines in a phase 2 clinical trial.
On October 12, aesthetic manufacturer Merz Aesthetics invited eight aesthetic practitioners to attend the first Belotero Lips London Masterclass hosted by nurse prescriber and Merz Innovation Partner Lee Garrett.
Medical aesthetic company Novus medical has launched a new device designed to treat snoring, called the Somnilase.
Global pharmaceutical company Allergan has received US Food and Drug Administration (FDA) approval for the use of Juvéderm VOLUMA XC with a TSK STERiGLIDE cannula for cheek augmentation to correct age-related volume definition in the mid-face in adults over 21.
The Advertising Standards Authority (ASA) has upheld an advert provided by British manufacturer LadyCare Menopause Ltd, previously known as LadyCare Lifetime Ltd, that was promoting the LadyCare device aiming to reduce menopausal symptoms.
US hair loss technology provider Kerastem has confirmed that patients who underwent the Phase 2 clinical trial in early-stage hair loss achieved an increase in mean terminal hair count in men with early hair loss when compared to the control group. Based on these results, Kerastem plans to begin a Phase 3 clinical trial later this year.
Skincare company iS Clinical has released the Tri-Active Exfoliating Masque, designed to smooth and polish the skin whilst simultaneously helping to minimise pore size and reduce the signs of ageing, the company explains.
Global pharmaceutical company Allergan has manufactured the 100 millionth vial of botulinum toxin type A Botox, which the company has said is a ‘significant milestone in the history of the brand’.
Global pharmaceutical company Allergan has launched Juvéderm VOLUX, a hyaluronic acid injectable gel that uses the existing VYCROSS patented technology.